Morocutti, A <br/><br/>
An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Nov 2006 
 - 1439-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2006.03137.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles--administration & dosage<br/>Adult<br/>Aged<br/>Antacids--administration & dosage<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Gastric Acid--metabolism<br/>Humans<br/>Male<br/>Middle Aged<br/>Rabeprazole<br/>Zollinger-Ellison Syndrome--drug therapy